ClinicalTrials.Veeva

Menu

Carbohydrates Distribution in Pregnancy Study (CHiPS)

G

Germans Trias i Pujol Hospital

Status

Completed

Conditions

Gestational Diabetes Mellitus in Pregnancy

Treatments

Behavioral: Intervention Treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT03378908
DMG-0001

Details and patient eligibility

About

Hypothesis: Patients with Gestational Diabetes Mellitus (GDM) have a high risk to develop complications during pregnancy, puerperium and in the newborn. At present there are not scientific evidences about the optimal distribution of meals in the medical nutrition therapy (MNT) and their relationship with glycemic control.

Aim: To explore and compare ketonemia and glycemic profile in patients with GDM that follow a MNT distributed in 6 or 3 meals. Besides, we want to explore the differences between both treatments in glucose dynamics.

Methods: The study design is a randomized, crossover and multicentric trial. A sample of 10 patients with GDM will be recruited in the Department of Endocrinology and Nutrition from both centres. In a randomized manner patients will follow the conventional treatment (a carbohydrate-controlled diet distributed in 6 meals: 3 main meals and 3 snacks) and the intervention treatment (a carbohydrate-controlled diet distributed in 3 meals: breakfast, lunch and dinner). They will be randomized to begin with one of the two treatments, and after two weeks they will be switched to the other treatment. Patients will wear a blinded continuous glucose monitoring device (iPro2-TM, Medtronic) during the entire study period.

Inclusion criteria:

  • Women with GDM diagnosed in 24-28 weeks.
  • Age 18-40 years.
  • Pregnancy age of 28-32 weeks.
  • Caucasian.
  • Body mass index ≤ 35 Kg/m2.

Exclusion criteria:

  • Unability to understand the dietary recommendations and/or to perform self-management of glycemia, ketonuria or ketonemia.
  • A low adherence to MNT.
  • Problems with written and/or oral communication.
  • Presence of comorbidities other than obesity, hypertension and dyslipidemia.
  • Insulin-need criteria within 3 first days of the beginning of the study (fasting glucose ≥90mg/dL, postprandial glucose 1-hour ≥140mg/dL).

Clinical and sociodemographic variables will be assessed. Dietary records and blood samples will be collected. Daily basal ketonuria and ketonemia before each meal will be assessed. Glycemic profile will be collected with a blind-sensor during the four weeks of the intervention study. Generalized linear model analysis will be performed. Statistical power will be 80% and significance level will be set at 0.05. Written informed consent will be collected from all participants.

Enrollment

10 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with GDM diagnosed in 24-28 weeks.
  • Age 18-40 years.
  • Pregnancy age of 28-32 weeks.
  • Caucasian.
  • Body mass index ≤ 35Kg/m2.
  • Firs-time mother.

Exclusion criteria

  • Disability to understand the dietary recommendations and/or to perform self-management of glycemia, ketonuria or ketonemia.
  • A low adherence to MNT.
  • Problems with write and oral communication.
  • Other comorbidities differed of obesity, hypertension and dyslipidemia.
  • Insulin criteria within 3 first days of study (fasting glucose ≥90mg/dL, postprandial glucose 1-hour ≥140mg/dL).

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Conventional Treatment 6 meals
No Intervention group
Description:
Diet will be distributed with 6 meals (breakfast, lunch, dinner and 3 snacks). This is the usual diet prescribed for women with GDM at the Department of Endocrinology and Nutrition of both Centers. Energy intake distribution: 25% breakfast, 5% snack, 30% lunch, 10% snack, 25% dinner and 5% snack.
Intervention Treatment 3 meals
Experimental group
Description:
Diet will be distributed in 3 meals (breakfast, lunch and dinner). Each meal will consist of the addition of the conventional meal and the next snack. Energy intake will be distributed: 30% breakfast (25% breakfast + 5% snack), 40% lunch (30% lunch + 10% snack) and 30% dinner (25% dinner and 5% snack).
Treatment:
Behavioral: Intervention Treatment

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems